Contrast echocardiography: evidence-based recommendations by European Association of EchocardiographySenior R, Becher H, Monaghan MJ, Agati L, Zamorano J, Vanoverschelde JL & Nihoyannopoulos P.
A comprehensive 18-page EAE-endorsed document outlining the evidence base for the use of contrast agents in all aspects of clinical cardiology.
Reference: Eur J Echocardiogr 2009; 10 (2); 194- 212
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography
Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, Burns PN, Castello R, Coon PD, Hagen ME, Jollis JG, Kimball TR, Kitzman DW, Kronzon I, Labovitz AJ, Lang RM, Mathew J, Moir WS, Nagueh SF, Pearlman AS, Perez JE, Porter TR, Rosenbloom J, Strachan GM, Thanigaraj S, Wei K, Woo A, Yu EH, Zoghbi WA.
A comprehensive 23-page document from the ASE providing a thorough overview of the principles of use of contrast agents and, similar to the EAE guideline, a summary of the evidence base supporting the use of contrast agents, including in the ITU and paediatric settings.
Reference: J Am Soc Echocardiogr. 2008; 21(11); 1179-201
A BSE-endorsed supplement outlining the evidence base for utilising contrast agents for the assessment of myocardial perfusion (using MCE). Detection of coronary disease, assessing severity of coronary disease, post infarct imaging and viability assessment are all discussed.
Reference: Eur J Echocardiogr 2007;8(3):S24-9
Other topics related to Contrast
- Historical & Landmark Papers
- Contrast for improving LV structural & functional assessment
- MCE for detection of myocardial ischaemia
- MCE for detection of myocardial viability
- MCE reviews & guidelines
- Safety of contrast agents
- Methodological Issues/Technique
- Left Ventricular Volumes and Regional Wall Motion
- Myocardial Perfusion